Latest news with #DanielContreras


Associated Press
28-05-2025
- Business
- Associated Press
Raadr Inc., Doing Business as Telvantis, Schedules Virtual Investor Call to Review Q1 25, Strategic Milestones and Future Outlook
NEW YORK, NY - May 28, 2025 ( NEWMEDIAWIRE ) - Raadr Inc. (OTC: RDAR), doing business as Telvantis ('Telvantis' or the 'Company'), a leading technology-driven telecommunications and enterprise solutions provider, today announced details of its upcoming virtual investor call scheduled for Monday, June 2, 2025, at 4:30 PM Eastern Time. This virtual meeting will provide investors with key insights into Telvantis' first quarter performance, recent strategic initiatives, significant financial achievements, and detailed plans for future growth. Telvantis leadership will deliver an informative update, followed by a dedicated question-and-answer session. Investors not yet registered for the Ambassador Program can sign up here: Upon registration, attendees will receive a confirmation email with instructions on how to join the meeting. Investors are encouraged to register early to secure their spot and may submit questions in advance by emailing [email protected] with the subject line 'Investor Call Question' by May 30, 2025. 'Transparent communication with our shareholders and investors is paramount at Telvantis,' said Daniel Contreras, CEO of Telvantis. 'We look forward to sharing tangible progress on our strategic initiatives, highlighting our recent achievements, and outlining our roadmap for continued growth. This meeting is a great opportunity to engage directly with our investors, address their questions, and reaffirm our commitment to long-term shareholder value.' Event Details: About Telvantis Raadr Inc., doing business as Telvantis (OTC: RDAR), is a U.S.-based telecommunications company delivering advanced solutions to operators, enterprises, and network providers worldwide. Leveraging extensive carrier relationships and proprietary CPaaS capabilities, Telvantis provides robust, high-volume messaging, voice, and digital communication services. With a strong presence and expanding partnerships in fintech, healthcare, and e-commerce, Telvantis is strategically positioned for continued growth and leadership in the evolving telecommunications market. Forward-looking statements This press release contains forward-looking statements that involve risks and uncertainties. These statements reflect the Company's current expectations regarding future events and are based on management's beliefs and assumptions. Actual results could differ materially due to various factors, including market conditions, competition, and the successful integration of acquired operations. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law Investor relations contact Raadr Inc., doing business as Telvantis, 1680 Michigan Avenue, Suite 700 Miami Beach, FL 33139 Email: [email protected] Website: View the original release on


Associated Press
19-05-2025
- Business
- Associated Press
Raadr Inc., Doing Business as Telvantis, Announces $1.4 Million Reduction in Note Obligation
NEW YORK - May 19, 2025 ( NEWMEDIAWIRE ) - Raadr Inc. (OTC: $RDAR), doing business as Telvantis ('Telvantis' or the 'Company'), today announced that it and JanBella Group, LLC ('JanBella') have agreed to amend the Company's note obligation to JanBella to a total of $400,000 - the original note had a principal amount of $540,000 and an additional $1,260,000 in conditional obligations, including an 18-month 10% 'fee tail' obligation on certain future funding. The revised $400,000 note balance is payable in four monthly installments, with the first payment having already been made by the Company. 'The increasing strength of our business operations has enabled us to take this decisive action, which, together with our previously announced share buyback program, delivers both short-term and long-term benefits,' said Daniel Contreras, CEO of Telvantis. 'Each of these actions, in their own way, creates meaningful long-term value for our shareholders,' Mr. Contreras added. 'We constantly seek to allocate our available cash where it offers attractive returns, and our ability to dramatically reduce our future obligations to JanBella was an opportunity that magnifies our ability and, importantly, our willingness to strike at the right time,' said Daniel Gilcher, CFO of Telvantis. Mr. Gilcher extended his comments by expressing the Company's gratitude to JanBella for working toward a mutually beneficial outcome. About Telvantis Raadr Inc., doing business as Telvantis (OTC: $RDAR), is a U.S.-based communications technology company powering global enterprise communication. Leveraging extensive carrier relationships and proprietary CPaaS capabilities, Telvantis delivers high-volume, reliable messaging, voice, and digital communication solutions. With a strong foothold and expanding partnerships in high-growth sectors like fintech, healthcare, and e-commerce, Telvantis is executing its strategy to become a leader in the communications technology space. The company is headquartered in Miami Beach, FL. Forward-looking Statements This press release contains forward-looking statements that involve risks and uncertainties. These statements reflect Telvantis' current expectations regarding future events and are based on management's beliefs and assumptions. Actual results could differ materially from those projected due to various factors, including market conditions, competition, and the successful integration of acquired operations. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Telvantis undertakes no obligation to update or revise any forward-looking statements, except as required by law. Investor Relations Contact Raadr Inc., doing business as Telvantis, 1680 Michigan Avenue, Suite 700 Miami Beach, FL 33139 Email: [email protected] Website: LinkedIn: Telvantis Twitter/X: @Telvantis View the original release on
Yahoo
17-05-2025
- Science
- Yahoo
Archaeologists Have Found Evidence of a Drug Room and ‘Snuff Tubes' at an Ancient Site in Peru
Archaeologists have discovered evidence of psychedelic drug use and 'snuff tubes" in a previously sealed-off room at an ancient site in Peru The researchers found the room at Chavín de Huántar, a major archaeological site in the Peruvian highlands constructed by the Chavín, a pre-Incan culture that flourished between 900 and 200 B.C. The small size of the room has led archaeologists to hypothesize that only a few Chavín elite were allowed to partake in the ritualistic drug useArchaeologists have discovered evidence of psychedelic drug use and 'snuff tubes" in a formally sealed-off chamber at an ancient site in Peru, according to a new study. The study, published in the peer-reviewed journal PNAS, states that the previously unknown chamber was discovered at Chavín de Huántar, an archaeological site in the Peruvian highlands constructed by the Chavín, a major pre-Incan culture that thrived between 900 and 200 B.C. The room was found to contain 23 artifacts 'associated with consumption of psychoactive plants' — including hollowed-out bird bones thought to be used as 'snuff tubes.' Further micro-botanical and chemical analyses confirmed traces of 'psychoactive plants" — also known as hallucinogens — and six of them specifically contained traces of tobacco and DMT, a drug commonly found in ayahuasca. The study's authors note that while Chavín rituals involving hallucinogenic drugs have 'long been hypothesized,' this is the first time these substances have been directly identified at the site. "The tubes are analogous to the rolled-up bills that high-rollers snort cocaine through in the movies," Daniel Contreras, an archaeologist at the University of Florida, told Live Science. "The tubes would have been used — we think — as inhalers for taking the snuff through the nose,' he added. Chavín de Huántar, located in the Peruvian highlands, was a center for ritual activity, according to the outlet. The large complex is made up of stone structures built around open plazas, and as additional structures were added over time, several rooms became interior spaces — which is how the room containing the 23 artifacts became hidden. In a statement to CBS News, Contreras further noted that the small size of the interior rooms — which could only hold a few people at a time — could indicate that drug use was used to reinforce social hierarchy, and that perhaps only an elite class was allowed to partake. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. "This is compelling evidence that psychoactive plants were part of formalized and tightly-controlled rituals rather than individual vision-quests or shamanic healing practices," Contreras told the outlet. "As such, they seem to have been an important element in the long-term transition from small egalitarian societies to large stratified ones, where social, political, and economic inequality were thought of as normal and to be expected rather than unusual," he added. Read the original article on People


Associated Press
14-05-2025
- Business
- Associated Press
Raadr Inc., Doing Business as Telvantis, Announces Completion of PCAOB Audit for Financial Statements 2023 and 2024, Confirms Revenue Target for the Year 2025 in the Range of $250-300 Million.
NEW YORK - May 14, 2025 ( NEWMEDIAWIRE ) - Raadr Inc. (OTC: $RDAR), doing business as Telvantis ('Telvantis' or the 'Company'), today announced the completion of its annual audit for the years 2023 and 2024. The audit of the Company's Financial Statements was conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States) ('PCAOB'). 'This audit is a major step for us as an emerging company with high aspirations. The team worked extremely hard, and we were able to complete this complex project in April,' said Daniel Contreras, CEO of Telvantis. 'We believe this is another building block to gain the trust of market participants and investors.' 'These audited financial statements provide the highest standard of transparency to all our shareholders, as required for all public companies listed on a major US stock exchange,' said Daniel Gilcher, CFO of Telvantis. 'By implementing proper processes and holding ourselves to a PCAOB standard, we ensure that we provide the market with accurate and reliable information about our Company.' The audited financial statements are available for viewing at and are discussed by management below. Consolidated Statement of Operations The newly formed group reported revenues of $47 million for the year 2024 compared to $315.5 million in the prior year. This drop was mainly attributed to the lack of available working capital financing. The gross profit amounted to $2.28 million in 2024 compared to $16.97 million in the prior year. The Company reduced its General and administrative spending to $4.2m in 2024, down from $5.2 million in the year prior, as a result of ongoing restructuring efforts throughout 2024. Sales and Market expenses dropped significantly to $0.6 million, down more than $2 million from $2.65 million in the year before. Importantly, the Company in its Irish subsidiary decided to write off a large receivable, which resulted in a one-off credit loss expense in total of $25.1 million for 2024 compared to a non-cash expense for Credit loss expense of $1.15 million in 2023. Total operating expenses, including costs of goods sold, amounted to $74.7 million compared to $307.5 million in the year prior. This reduction is again a direct function of our limited sales activity in 2024. These activities resulted in a Loss from operations of $27.7 million, including the $25.1 million write-off for 2024, and Income from Operations of $7.9 million for the year 2023. Interest expenses dropped by more than $3.5m to $3.1 million for the year 2024, compared to $6.6 million in the year prior. The year 2024, therefore, resulted in a Net Loss of $28.7 million for the group compared to a positive Net Income of $1.6 million in 2023. Consolidated Balance Sheet The Company ended the year 2024 with $1.4 million in Cash and equivalents, compared to 0.09 million on December 31, 2023. Accounts receivable, after substantial write-offs, amounted to $33.4 million at the end of 2024, compared to $72.9 million on December 31, 2023. Total current assets stood at $35.2 million at the end of 2024, compared to $74.2 million at the end of 2023. In 2024, the Company recorded a deferred tax asset of $2.2 million as a result of its substantial write-off, compared to $0.1 million in such assets at the end of the prior year 2023. The company's intangible assets, net of amortization, stood at $11 million on December 31, 2024, compared to $12.4 million the year before. Loan receivables from related parties amounted to $2.5 million at the end of 2024, compared to $4.5 million the year before. Total assets arrive at $54.6 million as of the balance sheet date in 2024 and $96.3 million as of December 31, 2024. This reduction is driven by both the write-off of receivables as well as the overall reduction in business activity through the year 2024. The Company's Accounts payable stood at $ 27.7 million at the end of 2024, down from $43.3 million the year before. Current loans payable were down to $7.1 million at the end of 2024, down from $ 46.2 million at the end of 2023. This reduction is driven by the restructuring of this facility as a long-term liability through 2024. Total Current Liabilities therefore decreased to $36.2 million by December 31, 2024, from $90.2 million as of December 31, 2023. Vice versa, Noncurrent loans payable stood at $ 41 million at the end of 2024. Total liabilities amounted to $82.2 million by the end of 2024, down $12.1 million from $94.3 million on the same day of the prior year. As a result, the Company's equity turned negative to $27.6 million compared to $1.9 million positive equity as of December 31, 2023. Consolidated Statement of Cash Flows The Company reported negative operating cash flows of $0.5 million for the year 2024, compared to negative $14 million in the prior year. The Company received $2.4 million in proceeds from loan receivables in 2024, compared to $3.3 million over the same period in 2023. Therefore, Net Cash used in Investing Activities amounted to $2.3 million for 2024, compared to $1.9 million in 2023. Cash Flow from Financing Activities amounted to negative $22 thousand for the year 2024, compared to positive $9.6 million driven by long-term debt issuance in 2023. Overall, the Company increased Cash and Cash Equivalents by $1.3 million during 2024 compared to a reduction of the same by $2.4 million during 2023. '2024 was a challenging year for the group with both operational headwinds and the group restructuring under Telvantis. Nevertheless, the 2024 results are disappointing. However, the steps we have taken to bring the business back on track are already showing impact in our 2025 financial performance,' commented Daniel Contreras. 'We have taken a conservative approach to write-offs, which negatively impacted our P/L in 2024. This is consistent with our approach to setting up the Company for long-term success. The executive team remains very confident in Telvantis' prospects. At this point, we can also confirm the revenue target discussed earlier this year in the range of $250-300 million,' added Daniel Gilcher. About Telvantis Raadr, Inc., doing business as Telvantis (OTC: $RDAR), is a U.S.-based communications technology company powering global enterprise communication. Leveraging extensive carrier relationships and proprietary CPaaS capabilities, Telvantis delivers high-volume, reliable messaging, voice, and digital communication solutions. With a strong foothold and expanding partnerships in high-growth sectors like fintech, healthcare, and e-commerce, Telvantis is executing its strategy to become a leader in the communications technology space. The company is headquartered in Miami Beach, FL. Forward-looking statements This press release contains forward-looking statements that involve risks and uncertainties. These statements reflect Telvantis' current expectations regarding future events and are based on management's beliefs and assumptions. Actual results could differ materially from those projected due to various factors, including market conditions, competition, and the successful integration of acquired operations. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Telvantis undertakes no obligation to update or revise any forward-looking statements, except as required by law. Investor Relations contact Raadr Inc., doing business as Telvantis 1680 Michigan Avenue, Suite 700 Miami Beach, FL 33139 Email: [email protected] Website: Twitter/X: @Telvantis LinkedIn: Telvantis View the original release on


Gizmodo
13-05-2025
- Science
- Gizmodo
Psychedelics Allowed Ancient Peruvians to Consolidate Power, Study Says
In a new study, archaeologists uncovered 2,500-year-old psychoactive drug paraphernalia in an archaeological site in the Peruvian highlands. Ancient Peruvians likely used psychedelics during intricate and exclusive rituals, according to the study's authors. The study, published May 5 in the Proceedings of the National Academy of Sciences, found that the ancient Chavín people, a pre-Incan society that dwelt in the Peruvian Andes, consumed tobacco and hallucinogenic plants during secretive rituals open only to an elite few. Chavín leaders may have controlled access to these trippy experiences as a way to gain prestige and influence. 'Taking psychoactives was not just about seeing visions. It was part of a tightly controlled ritual, likely reserved for a select few, reinforcing the social hierarchy,' Daniel Contreras, anthropological archaeologist at the University of Florida and co-author of the new study, said in a statement. Researchers already knew that intricate rituals were a big part of Chavín culture. To learn more about these rituals, a group of researchers from universities in the United States and in South America analyzed artifacts found at Chavín de Huántar, a UNESCO world heritage site in the Peruvian highlands. There, inside monumental stone structures, they uncovered what they suspected was ancient drug paraphernalia: hollow, cigarette-sized tubes made from bird bones. When the scientists conducted microscopic and chemical analyses of the hollow tubes, they found traces of a molecule similar to dimethyltryptamine (DMT), a powerful psychoactive compound that naturally occurs in plants that are native to Peru. DMT can cause brief, intense trips, complete with hallucinations. Researchers found these 'snuff tubes' in small private chambers, suggesting that access to the drugs was likely quite exclusive. Chavín people likely weren't using these drugs to have a good time. The scientists speculate that through these rituals, leaders established themselves as connected to the mystical and supernatural. By controlling access to these wild and powerful experiences, leaders might have been able to cement their status. So, these hallucinatory rituals might have also spurred fundamental changes in Chavín society, the study finds. The Chavín have been linked to earlier, more egalitarian societies. But the controlled access to weird, mystical experiences may help explain the transition over to the hierarchical societies that came later. 'The supernatural world isn't necessarily friendly, but it's powerful,' Contreras said. 'These rituals, often enhanced by psychoactives, were compelling, transformative experiences that reinforced belief systems and social structures.'